Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Therma Bright to begin US clinical performance study of its AcuVid COVID-19 Rapid Antigen Saliva Test

% of readers think this story is Fact. Add your two cents.


Therma Bright Inc (TSX-V:THRM, OTC:TBRIF), which is advancing its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test, said it will begin its US clinical performance study immediately.

In a statement, the company said the move comes after the Institutional Review Board’s (IRB) conditional approval on November 11, 2021.

Therma Bright said the clinical performance study, per US Food and Drug Administration (FDA) guidance, will begin immediately at three US-based clinics. The results will complement the Brazilian clinical study and other requested test data that have been submitted to the FDA over the past four months, beginning in July 2021.

READ: Therma Bright says ‘on track’ for FDA approval of its COVID-19 rapid antigen saliva test, AcuVid

“We’re pleased to have received IRB conditional approval for our U.S. clinical performance study,” said Rob Fia, CEO of Therma Bright. “Therma Bright can begin moving forward in our efforts with three pre-selected U.S. clinics. Based on current COVID-19 infection rates, we expect the study results to be delivered to the FDA within the next few weeks, as part of our AcuVid application for Emergency Use Authorization (EUA).”

Since mid-July 2021, the company said it has actively engaged with FDA executives, doctors, and scientists on its AcuVid COVID-19 Rapid Antigen Saliva Test application – and anticipates EUA following final FDA review.

Therma Bright is not making any express or implied claims that its test product has the ability to eliminate or cure COVID-19 or the SARS-CoV-2 virus.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Story by ProactiveInvestors



Source: https://www.proactiveinvestors.com/companies/news/966108/therma-bright-to-begin-us-clinical-performance-study-of-its-acuvid-covid-19-rapid-antigen-saliva-test-966108.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.